Literature DB >> 20821020

Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery.

Domenico Vitale, Vincenzo De Santis, Fabio Guarracino, Andrea Fontana, Fabio Pellegrini, Luigi Tritapepe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20821020     DOI： 10.1007/s00392-010-0208-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  12 in total

Review 1.  Hemodynamic management of patients in the first 24 hours after cardiac surgery.

Authors:  Arthur C St André; Anthony DelRossi
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

Review 2.  The role of the funny current in pacemaker activity.

Authors:  Dario DiFrancesco
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

3.  Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.

Authors:  Andreas Link; Jan Christian Reil; Simina Selejan; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2009-06-23       Impact factor: 5.460

4.  Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.

Authors:  X Monnet; B Ghaleh; P Colin; O P de Curzon; J F Giudicelli; A Berdeaux
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

5.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

Authors:  S F Vatner; R J McRitchie; E Braunwald
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

6.  Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade.

Authors:  J Tarnow; K Komar
Journal:  Anesthesiology       Date:  1988-06       Impact factor: 7.892

7.  Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients.

Authors:  J L Romson; J M Leung; W H Bellows; M Bronstein; F Keith; W Moores; K Flachsbart; R Richter; D Pastor; D M Fisher
Journal:  Anesthesiology       Date:  1999-11       Impact factor: 7.892

8.  Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.

Authors:  E Bollano; M Scharin Täng; A Hjalmarson; F Waagstein; B Andersson
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

9.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

10.  Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Michele Robertson; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321
View more
  7 in total

1.  Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.

Authors:  Robert S Hoke; Ursula Müller-Werdan; Christine Lautenschläger; Karl Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

2.  Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?

Authors:  Michele Correale; Deodata Montrone; Riccardo Ieva; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Clin Res Cardiol       Date:  2013-02-07       Impact factor: 5.460

3.  Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.

Authors:  Ruoyu Zhang; Dmitry Bobylev; Penelope Stiefel; Axel Haverich; Christoph Bara
Journal:  Clin Res Cardiol       Date:  2012-03-04       Impact factor: 5.460

Review 4.  Ivabradine: potential clinical applications in critically ill patients.

Authors:  Vincenzo De Santis; Domenico Vitale; Anna Santoro; Aurora Magliocca; Andrea Giuseppe Porto; Cecilia Nencini; Luigi Tritapepe
Journal:  Clin Res Cardiol       Date:  2012-10-14       Impact factor: 5.460

5.  Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and Ivabradine.

Authors:  Takeshi Kitai; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

6.  Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarction: study protocol for a randomized controlled trial.

Authors:  Nima Rudd; Ivan Subiakto; Muhammad Asrar Ul Haq; Vivek Mutha; William J Van Gaal
Journal:  Trials       Date:  2014-09-07       Impact factor: 2.279

7.  Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome.

Authors:  Vincenzo De Santis; Giacomo Frati; Ernesto Greco; Luigi Tritapepe
Journal:  Clin Res Cardiol       Date:  2014-05-08       Impact factor: 5.460
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.